
Sitaramesh Emani MD (He/Him)
Heart Failure & Transplantation, Interventional Cardiology
Director of Heart Failure Clinical Trials, The Christ Hospital Cincinnati, OH
Join to view full profile
2123 Auburn AveSte 138Cincinnati, OH 45219
Phone+1 513-206-1180
Fax+1 513-206-1182
Dr. Emani is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sitaramesh Emani is a cardiologist based in Cincinnati, OH. He specializes in Heart Failure & Transplantation and Interventional Cardiology. Dr. Emani completed his residency in Internal Medicine at Washington University/B-JH/SLCH Consortium and continued with three fellowships in Cardiovascular Disease, Advanced Heart Failure and Transplant Cardiology, and Interventional Cardiology at Ohio State University Hospital. He is also the Director of Heart Failure Clinical Trials at the Christ Hospital in Cincinnati. He has experience in numerous novel technologies to treat both acute and chronic heart failure, and focuses on new device-based therapies for heart failure treatment.
Education & Training
Ohio State University HospitalFellowship, Interventional Cardiology, 2018 - 2019
Ohio State University HospitalFellowship, Advanced Heart Failure and Transplant Cardiology, 2012 - 2013
Ohio State University HospitalFellowship, Cardiovascular Disease, 2009 - 2012
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2006 - 2009
Ohio State University College of MedicineClass of 2006
Certifications & Licensure
OH State Medical License 2009 - 2027
MO State Medical License 2006 - 2009
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Clinical Trials
- Ketogenic Diet in Patients With Heart Failure Start of enrollment: 2019 Dec 22
Publications & Presentations
PubMed
- Cardiotropic Adeno-Associated Virus-Based Gene Therapy via Intracoronary Delivery for Nonischemic Heart Failure.Joseph Abraham, Eugene S Chung, Sitaramesh Emani, Ankit Bhatia, Gregory Egnaczyk
Canadian Journal of Physiology and Pharmacology. 2026-08-19 - 1 citationsEstimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF II.Andrew A Girard, Uma Mylavarapu, Jan Komtebedde, Suzanne V Arnold, Scott D Solomon
Circulation. Population Health and Outcomes. 2026-01-01 - 4 citationsEpicardial Adipose Tissue, Functional Status, and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction.Yoran Crum, Dirk J van Veldhuisen, Sanjiv J Shah, Uma Mylavarapu, Mo Hu
JACC. Advances. 2025-12-01
Journal Articles
- Anticoagulation Management Following Left Ventricular Assist Device Implantation Is Similar Across All Provider StrategiesBrent C Lampert, Sitaramesh Emani, Ahmet Kilic, Bryan A Whitson, Interactive Cardiovascular and Thoracic Surgery
Press Mentions
Cincinnati Doctors Among First in Nation to Implant New Device to Treat Heart FailureJuly 23rd, 2024
InterShunt Enrolls First Patient in New Heart Failure StudyJune 30th, 2025
InterShunt Initiates Study of Device for Heart Failure TreatmentJuly 1st, 2025
Professional Memberships
- Member
- International Society of Heart and Lung TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









